Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |